An eye drop for macular degeneration shows promise in animal studies

Drugs such as Roche’s Lucentis and Regeneron’s Eylea help slow down the progression of age-related macular degeneration (AMD), a leading cause of blindness in people over age 65. But those medicines have to be injected into the eye, making them inconvenient for patients.